MedTrace Logo

Hormones and Sexual Function Predict Outcomes in Revascularized Men With Diabetes

NCT01190904 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 568

Last updated 2016-08-11

No results posted yet for this study

Summary

The purpose of this study is to find out if androgen deficiency (low levels of testosterone, a male hormone produced by the sex glands) and erectile dysfunction (sexual dysfunction) will predict over time the development of a heart attack, stroke, or death in men with Diabetes Mellitus who have angiographically proven coronary artery disease (CAD) (≥50%) with or without percutaneous coronary intervention (PCI). A substudy aims to show the different factors and processes that may show a relationship between sexual function and levels of androgen in the body to heart disease.

Conditions

Sponsors & Collaborators

Principal Investigators

  • Mary Ann McLaughlin, MD, MPH · Icahn School of Medicine at Mount Sinai

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-01-31
Primary Completion
2016-07-31
Completion
2016-07-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01190904 on ClinicalTrials.gov